FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States

Company positions itself as the central research hub for patients, clinicians, and compounding pharmacies tracking the ...